Gland Pharma Limited — Board Meeting, 26-02-2025: Outcome of Board Meeting

The Board of Gland Pharma Limited has announced a board meeting outcome, approving the "Gland Pharma Employee Stock Option Scheme, 2025" (ESOP Scheme, 2025) for granting stock options to eligible employees. The scheme involves 29,82,124 options, with an exercise price to be determined by the ESOP Compensation Committee, potentially at a discount of up to 50% on market price or ₹750, whichever is higher. Approval from shareholders will be sought via postal ballot for this scheme, aiming to enhance employee motivation and retention.